• BARDA Reselects ICON as Preferred Partner contractpharma
    October 30, 2020
    ​ICON plc, a global CRO, has been re-selected by the Biomedical Advanced Research and Development Authority (BARDA) to continue being part of its exclusive Medical Countermeasures Clinical Studies Network (CSN).
PharmaSources Customer Service